Depression neuropathology is linked with RAS over‐activity, and selective inhibition of AngII/AT1 or activation of AngII/AT2 and AngII/Ang1‐7/MASR could be a therapeutic way of attenuating depression. The gene discussed is AGTR2; the disease is depressive symptom measurement.